ID16662A - Senyawa antibakteri karbapenem komposisi yang mengandung senyawa tersebut serta metode pengobatannya - Google Patents

Senyawa antibakteri karbapenem komposisi yang mengandung senyawa tersebut serta metode pengobatannya

Info

Publication number
ID16662A
ID16662A IDP971350A ID971350A ID16662A ID 16662 A ID16662 A ID 16662A ID P971350 A IDP971350 A ID P971350A ID 971350 A ID971350 A ID 971350A ID 16662 A ID16662 A ID 16662A
Authority
ID
Indonesia
Prior art keywords
carbapenems
compound
composition
treatment method
antibacterial compounds
Prior art date
Application number
IDP971350A
Other languages
English (en)
Indonesian (id)
Inventor
Robert R Wilkening
Ronald W Ratcliffe
Timothy A Blizzard
Original Assignee
Merck & Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9609741.5A external-priority patent/GB9609741D0/en
Application filed by Merck & Co Ltd filed Critical Merck & Co Ltd
Publication of ID16662A publication Critical patent/ID16662A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/14—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 3
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IDP971350A 1996-04-24 1997-04-23 Senyawa antibakteri karbapenem komposisi yang mengandung senyawa tersebut serta metode pengobatannya ID16662A (id)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1618496P 1996-04-24 1996-04-24
GBGB9609741.5A GB9609741D0 (en) 1996-05-10 1996-05-10 Carbapenem antibacterial compounds compositions containing such componds and methods of treatment

Publications (1)

Publication Number Publication Date
ID16662A true ID16662A (id) 1997-10-30

Family

ID=26309297

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP971350A ID16662A (id) 1996-04-24 1997-04-23 Senyawa antibakteri karbapenem komposisi yang mengandung senyawa tersebut serta metode pengobatannya

Country Status (31)

Country Link
EP (1) EP0906313B1 (zh)
JP (1) JP3176068B2 (zh)
KR (1) KR20000010599A (zh)
CN (1) CN1074767C (zh)
AR (1) AR006810A1 (zh)
AT (1) ATE260915T1 (zh)
AU (1) AU707459B2 (zh)
BG (1) BG102949A (zh)
BR (1) BR9708864A (zh)
CA (1) CA2252402C (zh)
CO (1) CO4990968A1 (zh)
CZ (1) CZ340798A3 (zh)
DE (1) DE69727931T2 (zh)
EA (1) EA001296B1 (zh)
EE (1) EE03689B1 (zh)
ES (1) ES2216142T3 (zh)
HK (1) HK1021186A1 (zh)
HR (1) HRP970213A2 (zh)
HU (1) HUP9901778A3 (zh)
ID (1) ID16662A (zh)
IL (1) IL126480A0 (zh)
IS (1) IS4861A (zh)
NO (1) NO984949L (zh)
NZ (1) NZ332183A (zh)
PE (1) PE64298A1 (zh)
PL (1) PL186881B1 (zh)
SK (1) SK283550B6 (zh)
TR (1) TR199802140T2 (zh)
TW (1) TW539677B (zh)
WO (1) WO1997040048A1 (zh)
YU (1) YU46298A (zh)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7163522B1 (en) 1994-03-02 2007-01-16 Scimed Life Systems, Inc. Block copolymer elastomer catheter balloons
US6406457B1 (en) 1994-03-02 2002-06-18 Scimed Life Systems, Inc. Block copolymer elastomer catheter balloons
US5908936A (en) * 1997-05-13 1999-06-01 Merck & Co., Inc. Process for synthesizing carbapenem intermediates
CA2287931A1 (en) * 1997-05-13 1998-11-19 Merck & Co., Inc. Process for synthesizing carbapenem intermediates
US6140318A (en) 1997-10-23 2000-10-31 Merck & Co., Inc. Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
CA2306698A1 (en) * 1997-10-23 1999-04-29 Merck & Co., Inc. Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
CA2306565A1 (en) * 1997-10-23 1999-04-29 Merck & Co., Inc. Carbapenem antibacterial compounds, compositions and methods of treatment
US6271222B1 (en) * 1998-05-28 2001-08-07 Merck & Co., Inc. Penem antibacterial compounds, compositions and methods of treatment
DE69916287T2 (de) * 1998-06-17 2005-03-24 Merck & Co., Inc. Verfahren zur synthese von carbapenem-zwischenprodukten
EP1089729A4 (en) * 1998-06-25 2002-11-06 Merck & Co Inc ANTIBACTERIAL CARBAPENEM COMPOUNDS, COMPILATIONS THAT CONTAIN THEM AND TREATMENT METHODS
CA2335571A1 (en) * 1998-06-25 1999-12-29 Merck & Co. Inc. (heterocyclic) methyl substituted carbapenem antibacterials
US7672747B2 (en) 2000-03-30 2010-03-02 Lam Research Corporation Recipe-and-component control module and methods thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0429341A3 (en) * 1989-11-20 1991-11-13 Rhone-Poulenc Sante Heterocyclic derivatives, their preparation and pharmaceuticals containing them
FR2661177A1 (fr) * 1990-04-23 1991-10-25 Rhone Poulenc Sante Derives du naphtosultame antagonistes de la serotonine, leur preparation et les medicaments les contenant.
US5451579A (en) * 1994-02-15 1995-09-19 Merck & Co., Inc. 1-β-methyl-carbapenem, compositions containing same and methods of use

Also Published As

Publication number Publication date
HK1021186A1 (en) 2000-06-02
PL186881B1 (pl) 2004-03-31
WO1997040048A1 (en) 1997-10-30
TW539677B (en) 2003-07-01
EE03689B1 (et) 2002-04-15
EE9800355A (et) 1999-04-15
JPH11508279A (ja) 1999-07-21
KR20000010599A (ko) 2000-02-15
NZ332183A (en) 2000-05-26
BG102949A (bg) 1999-10-29
EP0906313B1 (en) 2004-03-03
PL329376A1 (en) 1999-03-29
CA2252402C (en) 2002-12-24
EP0906313A1 (en) 1999-04-07
BR9708864A (pt) 1999-08-03
AR006810A1 (es) 1999-09-29
CN1222912A (zh) 1999-07-14
NO984949D0 (no) 1998-10-23
ES2216142T3 (es) 2004-10-16
CN1074767C (zh) 2001-11-14
PE64298A1 (es) 1998-10-30
YU46298A (sh) 2000-03-21
SK145498A3 (en) 1999-10-08
IS4861A (is) 1998-10-06
CA2252402A1 (en) 1997-10-30
SK283550B6 (sk) 2003-09-11
AU707459B2 (en) 1999-07-08
CO4990968A1 (es) 2000-12-26
ATE260915T1 (de) 2004-03-15
TR199802140T2 (xx) 1999-01-18
EA199800949A1 (ru) 1999-04-29
IL126480A0 (en) 1999-08-17
EA001296B1 (ru) 2000-12-25
DE69727931D1 (de) 2004-04-08
HRP970213A2 (en) 1998-06-30
HUP9901778A2 (hu) 1999-09-28
HUP9901778A3 (en) 2000-06-28
NO984949L (no) 1998-12-21
CZ340798A3 (cs) 1999-03-17
JP3176068B2 (ja) 2001-06-11
DE69727931T2 (de) 2005-04-14
AU2462997A (en) 1997-11-12

Similar Documents

Publication Publication Date Title
AU1721697A (en) Use of compositions comprising stabilized biologically effective compounds
DE69739583D1 (de) Topische zusammensetzungen enthaltend als therapeutisch aktiven wirkstoff ein monoglycerid zur behandlung von schleimhautinfektionen
ID16493A (id) Perlakuan bahan yang mengandung padatan yang diambil dari efluen
ZA973487B (en) Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment.
ID16662A (id) Senyawa antibakteri karbapenem komposisi yang mengandung senyawa tersebut serta metode pengobatannya
EP0975654A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF CYTOMEGALOVIRUS INFECTIONS
AU7961498A (en) 9a-azalides, compositions containing such compounds and methods of treatment
IL142776A0 (en) Use of phosphonoformic acid derivatives for treating infections
AU7986098A (en) 9a-aza-3-ketolides, compositions containing such compounds and methods of treatment
NO982562D0 (no) Sammensetning for behandling av smerte
EP1021445A4 (en) ANTIBACTERIAL CARBAPENEM COMPOSITIONS, PREPARATIONS CONTAINING SAME, AND METHODS OF TREATMENT
IL124764A0 (en) Topical composition for treatment of baldness
EP1084105A4 (en) CARBAPENEM ANTIBACTERIAL COMPOUNDS, COMPOSITIONS CONTAINING THE SAME, AND METHODS OF TREATMENT
EP0977567A4 (en) ANTIBACTERIAL CARBAPENEM COMPOUNDS, CONTAINING COMPOSITIONS AND TREATMENT METHODS
EP1032384A4 (en) ANTIBACTERIAL COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING CARBAPENEMAS
EP1027352A4 (en) ANTIBACTERIAL CARBAPENEM COMPOUNDS, COMPOSITIONS AND TREATMENT METHODS
EP1027353A4 (en) ANTIBACERIAL CARBAPENEM COMPOUNDS, COMPOSITIONS THAT CONTAIN THESE AND TREATMENT METHODS
PL348354A1 (en) Use of phosphonoformic acid derivatives for treating infections
AU3215395A (en) Carbapenem compounds, compositions and methods of treatment
GB9624277D0 (en) Carbapenem antibacterial compounds compositions containing such compounds and methods of treatment
GB9815806D0 (en) Carbapenem antibacterial compounds compositions containing such compounds and methods of treatment
GB9807942D0 (en) Carbapenem antibacterial compounds compositions containing such compounds and methods of treatment
EP1089730A4 (en) CARBAPENEM-BASED ANTIBACTERIAL COMPOUNDS, COMPOSITIONS CONTAINING SAME, AND THERAPEUTIC METHODS
EP1089729A4 (en) ANTIBACTERIAL CARBAPENEM COMPOUNDS, COMPILATIONS THAT CONTAIN THEM AND TREATMENT METHODS
GB9609741D0 (en) Carbapenem antibacterial compounds compositions containing such componds and methods of treatment